Specialty Connect

A Focus on Immune-Mediated Skin Conditions

Tuesday, Oct. 11, 2022

Program: 1:00–5:30pm ET

Networking Reception: 5:30pm–6:30pm ET
AMCP Members: $195
AMCP Non-Members: $225

Multiple skin conditions — including psoriasis, atopic dermatitis, and alopecia areata — are mediated by complex immunological pathways that drive disease onset and progression. Recent years have seen the introduction of novel targeted therapies inhibit cytokines that play key roles in these pathways, and many more related therapies are in development. Targeted immune-modulating therapies offer patients with moderate to severe disease additional opportunities to achieve and maintain disease control. However, the rapidly growing therapeutic armamentarium presents challenges for managed care professionals seeking to develop and implement evidence-based, patient-centered policies to ensure that the right patient has access to the right therapy at the right time. During Specialty Connect, experts will focus on managed care considerations for managing immune-mediated skin conditions. Topics will include the future pipeline, considerations for treatment selection, and formulary and financial risk management strategies.  

Specialty Connect is a strategic, forward-thinking pre-conference program designed to focus on topics important to those involved with specialty management. The program is designed for and with industry leaders, experts, and managed care professionals operating in this fast-growing sector and will provide opportunities to both learn and network with those interested in specialty management.

Draft Agenda (Agenda will be updated regularly)

1:00–1:05pm    Welcome and Introductions  
1:05–1:50pm    Overview of the Natural History and Burden of Immune-Mediated Skin Conditions  
1:50–2:35pm    New and Emerging Targeted Therapies for Immune-Mediated Skin Conditions  
2:35–2:55pm    Break  
2:55–3:40pm    Evidence-Based and Patient-Specific Considerations for Optimizing Treatment Outcomes  
3:40–4:40pm    Payer Perspectives on Treatment Decision-Making and Access  
4:40–5:25pm    Panel Discussion  
5:25–5:30pm    Closing  


ACPE logo

The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). Pharmacists can earn a maximum of 4 contact hours of CPE credit by attending all CPE sessions during Specialty Connect (not including the satellite symposium held in conjunction with the conference). To obtain credit, pharmacists must attend a session in its entirety, participate in session-specific learning assessments, obtain a session-specific attendance code, complete a session evaluation, and record their participation online at amcplearn.org no later than 11:59 PM PT on Monday, Nov. 7, 2022. No exceptions can be made after this date. 

Visit our CPE Information & Policies page for additional information on AMCP’s continuing pharmacy education policies. 

Statement of Commercial Support: This activity is supported by independent educational grants from Incyte Corporation, Sanofi and Regeneron Pharmaceuticals, Novartis Pharmaceuticals Corporation, Pfizer Inc., and Boehringer Ingelheim Pharmaceuticals Inc.